Alliance Boots in deal with Beijing Med-Pharm for GP Corp

5 February 2007

Beijing Med-Pharm says that an entity formed by it and Alliance Boots, Europe's leading pharmacy-led health and beauty group, has agreed to acquire a 50% interest in Guangzhou Pharmaceuticals Corp, the third largest pharmaceutical wholesaler in China.

Alliance BMP, the UK-based investment vehicle formed by Alliance Boots and Beijing Med-Pharm, will take a 50% interest in GP Corp for 545.0 million renminbi ($69.0 million) in cash, constituting of a direct capital injection into the latter. Alliance Boots will own 80% of Alliance BMP and Beijing Med-Pharm 20%. Alliance BMP will hold four of the eight GP Corp board seats. David Gao, who played a key role in the negotiations for the transaction with GP Corp, will continue as chief executive of Beijing Med-Pharm, and will serve as chairman of GP Corp. The formation of Alliance BMP also creates a vehicle through which Beijing Med-Pharm and Alliance Boots can make additional investments in China.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight